Invention Application
- Patent Title: Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
-
Application No.: US17212424Application Date: 2021-03-25
-
Publication No.: US20210308220A1Publication Date: 2021-10-07
- Inventor: Omoniyi Adedokun , Daphne Chan , Yang Chen , Philippe Szapary
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K16/24 ; A61P1/00 ; A61P37/06
Abstract:
A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequence subcutaneous doses.
Public/Granted literature
- US12138295B2 Methods of treating Crohn's disease with anti-IL23 specific antibody Public/Granted day:2024-11-12
Information query
IPC分类:
